China Brain-Computer Interface Startup Jieti Medical Begins IPO Tutoring

The significance here is procedural rather than commercial: pre-IPO tutoring is the first formal gate in the mainland listing pipeline, so a brain-computer interface developer clearing it signals that regulators are willing to let a still-pre-revenue, deep-tech category move toward public markets. That matters most for the cluster of Chinese BCI peers that have been confined to private funding, and for the venture backers seeking an exit route. Whether tutoring advances to an actual filing, and how the company's technology and revenue profile are framed in disclosure, is the open question worth watching.